2002
DOI: 10.1111/j.1348-0421.2002.tb02742.x
|View full text |Cite
|
Sign up to set email alerts
|

Evaluation of Therapeutic Efficacy of Adjuvant Helicobacter pylori Whole Cell Sonicate in Mice with Chronic H. pylori Infection

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

2
8
0

Year Published

2006
2006
2012
2012

Publication Types

Select...
9
1

Relationship

2
8

Authors

Journals

citations
Cited by 19 publications
(10 citation statements)
references
References 21 publications
2
8
0
Order By: Relevance
“…It is known that Al(OH) 3 is already approved for use as an adjuvant in humans because of its safety and stability. In case of the H. pylori vaccine, systemic immunization with H. pylori antigens in aluminum adjuvants has shown to induce immune protection to a certain degree in different animal models [22,25,26]. Our study also suggested that Mongolian gerbils were partly protected from H. pylori infection by intramuscular administration with H. pylori vaccines comprising different recombinant antigens combined with aluminum adjuvants.…”
Section: Discussionsupporting
confidence: 54%
“…It is known that Al(OH) 3 is already approved for use as an adjuvant in humans because of its safety and stability. In case of the H. pylori vaccine, systemic immunization with H. pylori antigens in aluminum adjuvants has shown to induce immune protection to a certain degree in different animal models [22,25,26]. Our study also suggested that Mongolian gerbils were partly protected from H. pylori infection by intramuscular administration with H. pylori vaccines comprising different recombinant antigens combined with aluminum adjuvants.…”
Section: Discussionsupporting
confidence: 54%
“…However, many vaccine studies that focused on inducing Th2 immunity used an H. pylori sonicate preparation that contained H. pylori LPS [14,[19][20][21]. Thus, these studies using H. pylori sonicate may not have optimally induced Th2 biased H. pylori specific immunity.…”
Section: Introductionmentioning
confidence: 99%
“…In an attempt to provide an option other than triple therapy, we have studied the effectiveness of preventive or therapeutic vaccinations against H. pylori infection (13,16,22,23), the mechanisms of which remain to be clarified. In the present study, we examined whether DCs pulsed with H. pylori antigens reduced bacterial loads in the stomachs of mice with chronic H. pylori infections and tried to clarify the mechanisms involved to test the feasibility of DC-based immunotherapy against chronic H. pylori infection.…”
mentioning
confidence: 99%